PMID- 31463438 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240204 IS - 2572-1143 (Electronic) IS - 2572-1143 (Linking) VI - 1 IP - 1 DP - 2018 Mar TI - Link N as a therapeutic agent for discogenic pain. PG - e1008 LID - 10.1002/jsp2.1008 [doi] LID - e1008 AB - Neurotrophins (NTs) are the major contributors of sensory axonal sprouting, neural survival, regulation of nociceptive sensory neurons, inflammatory hyperalgesia, and neuropathic pain. Intervertebral disc (IVD) cells constitutively express NTs. Their expression is upregulated by proinflammatory cytokines present in the IVD during degeneration, which can promote peripheral nerve ingrowth and hyperinnervation, leading to discogenic pain. Currently, there are no targeted therapies that decrease hyperinnervation in degenerative disc disease. Link N is a naturally occurring peptide with a high regenerative potential in the IVD. Therefore, the suitability of Link N as a therapeutic peptide for suppressing NTs, which are known modulators and mediators of pain, was investigated. The aim of the present study is to determine the effect of Link N on NTs expression, nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and their cognate receptors TrkA and TrkB as they are directly correlated with symptomatic back pain. Furthermore, the neurotransmitter (substance P) was also evaluated in human annulus fibrosus (AF) cells stimulated with cytokines. Human AF cells isolated from normal IVDs were stimulated with interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) in the presence or absence of Link N. NGF release in the media was evaluated by Western blotting. Total RNA was isolated and gene expression was measured using real-time PCR. Gene expression of NGF, BDNF, TrkA, and TrkB significantly decreased in human disc cells stimulated with either IL-1beta or TNF-alpha supplemented with Link N when compared to the cells stimulated only with IL-1beta or TNF-alpha. NGF protein expression was also suppressed in AF cells coincubated with Link N and IL-1beta when compared to the cells stimulated only with IL-1beta. Link N can suppress the stimulation of NGF, BDNF, and their receptors TrkA and TrkB in AF cells in an inflammatory milieu. Thus, coupled with previous observations, this suggests that administration of Link N has the potential to not only repair the discs in early stages of the disease but also suppress pain. FAU - Noorwali, Hussain AU - Noorwali H AD - Division of Orthopaedic Surgery McGill University Montreal QC Canada. AD - SMBD-Jewish General Hospital Lady Davis Institute for Medical Research Montreal QC Canada. AD - Division of Orthopaedic Surgery King Abdulaziz University Jeddah Saudi Arabia. FAU - Grant, Michael P AU - Grant MP AUID- ORCID: 0000-0003-3758-5009 AD - SMBD-Jewish General Hospital Lady Davis Institute for Medical Research Montreal QC Canada. FAU - Epure, Laura M AU - Epure LM AD - SMBD-Jewish General Hospital Lady Davis Institute for Medical Research Montreal QC Canada. FAU - Madiraju, Padma AU - Madiraju P AD - SMBD-Jewish General Hospital Lady Davis Institute for Medical Research Montreal QC Canada. FAU - Sampen, Hee-Jeong AU - Sampen HJ AD - Department of Biochemistry Rush University Medical Center Chicago Illinois. FAU - Antoniou, John AU - Antoniou J AD - Division of Orthopaedic Surgery McGill University Montreal QC Canada. AD - SMBD-Jewish General Hospital Lady Davis Institute for Medical Research Montreal QC Canada. FAU - Mwale, Fackson AU - Mwale F AD - Division of Orthopaedic Surgery McGill University Montreal QC Canada. AD - SMBD-Jewish General Hospital Lady Davis Institute for Medical Research Montreal QC Canada. LA - eng GR - R01 AR062136/AR/NIAMS NIH HHS/United States GR - R21 AR067935/AR/NIAMS NIH HHS/United States PT - Journal Article DEP - 20180315 PL - United States TA - JOR Spine JT - JOR spine JID - 101722350 PMC - PMC6686832 OTO - NOTNLM OT - Link N OT - discogenic pain OT - intervertebral disc OT - low back pain COIS- The authors declare no potential conflict of interests. EDAT- 2018/03/15 00:00 MHDA- 2018/03/15 00:01 PMCR- 2018/03/15 CRDT- 2019/08/30 06:00 PHST- 2018/01/15 00:00 [received] PHST- 2018/02/19 00:00 [revised] PHST- 2018/02/19 00:00 [accepted] PHST- 2019/08/30 06:00 [entrez] PHST- 2018/03/15 00:00 [pubmed] PHST- 2018/03/15 00:01 [medline] PHST- 2018/03/15 00:00 [pmc-release] AID - JSP21008 [pii] AID - 10.1002/jsp2.1008 [doi] PST - epublish SO - JOR Spine. 2018 Mar 15;1(1):e1008. doi: 10.1002/jsp2.1008. eCollection 2018 Mar.